Vanguard Investments Australia
PGEN icon

Vanguard Investments Australia’s Precigen PGEN Stock Holding History

Vanguard Investments Australia’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$261K Hold
45,834
– – ﹤0.01% 1988
2026
Q1 		$177K Buy
+45,834
New +$188K ﹤0.01% 2089

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Investments Australia's PGEN Position: Q2 2026 in Review

Vanguard Investments Australia held its Precigen (PGEN) position steady in Q2 2026 at 45,834 shares worth $261K. The position accounts for ﹤0.01% of the portfolio, ranked #1988.

Vanguard Investments Australia first reported a position in PGEN in Q1 2026 and has held it in 2 quarters since. 197 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Vanguard Investments Australia held 45,834 shares of Precigen worth $261K as of Q2 2026.
  • Vanguard Investments Australia left its Precigen share count unchanged in Q2 2026.
  • Precigen made up ﹤0.01% of Vanguard Investments Australia's portfolio in Q2 2026, its #1988 holding.
  • Vanguard Investments Australia first reported a position in Precigen in Q1 2026 and has held it in 2 quarters since.
  • 197 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Vanguard Investments Australia's 13F filing for Q2 2026, filed 13 Aug 2026.